138 related articles for article (PubMed ID: 21792081)
1. Assessment of trypsinogen-2 levels as an early diagnostic for post-endoscopic retrograde cholangiopancreatography pancreatitis.
Kobayashi K; Sasaki T; Serikawa M; Inoue M; Itsuki H; Chayama K
Pancreas; 2011 Nov; 40(8):1206-10. PubMed ID: 21792081
[TBL] [Abstract][Full Text] [Related]
2. Increased serum trypsinogen 2 and trypsin 2-alpha 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy.
Kemppainen E; Hedström J; Puolakkainen P; Halttunen J; Sainio V; Haapiainen R; Kivilaakso E; Stenman UH
Gut; 1997 Nov; 41(5):690-5. PubMed ID: 9414980
[TBL] [Abstract][Full Text] [Related]
3. Urinary trypsinogen-2 test strip in detecting ERCP-induced pancreatitis.
Kemppainen E; Hedström J; Puolakkainen P; Halttunen J; Sainio V; Haapiainen R; Stenman UH
Endoscopy; 1997 May; 29(4):247-51. PubMed ID: 9255526
[TBL] [Abstract][Full Text] [Related]
4. Pain at 24 hours associated with amylase levels greater than 5 times the upper normal limit as the most reliable indicator of post-ERCP pancreatitis.
Testoni PA; Bagnolo F
Gastrointest Endosc; 2001 Jan; 53(1):33-9. PubMed ID: 11154486
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil activation and hyperamylasaemia after endoscopic retrograde cholangiopancreatography: potential role for the leukocyte in the pathogenesis of acute pancreatitis.
Mann DV; Kalu P; Foulds S; Edwards R; Glazer G
Endoscopy; 2001 May; 33(5):448-53. PubMed ID: 11396766
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a rapid urine amylase test using post-ERCP hyperamylasemia as a model.
Hegewald MJ; Isenberg G; Sterling RK; Cooper GS; Chak A; Sivak MV
Am J Gastroenterol; 2001 Sep; 96(9):2640-5. PubMed ID: 11569688
[TBL] [Abstract][Full Text] [Related]
7. Increased serum trypsinogen 2 and trypsin 2-1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography (ERCP)-induced pancreatitis with high accuracy.
Baillie J
Gastrointest Endosc; 1998 Jun; 47(6):554-5. PubMed ID: 9647391
[No Abstract] [Full Text] [Related]
8. Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis.
Testoni PA; Bagnolo F; Caporuscio S; Lella F
Am J Gastroenterol; 1999 May; 94(5):1235-41. PubMed ID: 10235200
[TBL] [Abstract][Full Text] [Related]
9. Twenty-four-hour serum amylase predicting pancreatic reaction after endoscopic sphincterotomy.
Testoni PA; Caporuscio S; Bagnolo F; Lella F
Endoscopy; 1999 Feb; 31(2):131-6. PubMed ID: 10223361
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of ERCP- and endoscopic sphincterotomy-induced pancreatic damage: a prospective study on the time course and the significance of serum levels of pancreatic secretory enzymes.
Doppl WE; Weber HP; Temme H; Klör HU; Federlin K
Eur J Med Res; 1996 Mar; 1(6):303-11. PubMed ID: 9367944
[TBL] [Abstract][Full Text] [Related]
11. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP.
Arvanitidis D; Hatzipanayiotis J; Koutsounopoulos G; Frangou E
Hepatogastroenterology; 1998; 45(19):248-52. PubMed ID: 9496522
[TBL] [Abstract][Full Text] [Related]
12. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes.
Gottlieb K; Sherman S; Pezzi J; Esber E; Lehman GA
Am J Gastroenterol; 1996 Aug; 91(8):1553-7. PubMed ID: 8759660
[TBL] [Abstract][Full Text] [Related]
13. The effect of ERCP on circulating pancreatic enzymes and pancreatic protease inhibitors.
Conn M; Goldenberg A; Concepcion L; Mandeli J
Am J Gastroenterol; 1991 Aug; 86(8):1011-4. PubMed ID: 1713406
[TBL] [Abstract][Full Text] [Related]
14. Determination of elastase-1 serum levels in post ERCP/EST pancreatic damage.
Hardt PD; Fadgyas T; Kress O; Doppl WE; Weber HP; Bimler EA; Temme H; Klör HU
Z Gastroenterol; 1999 Aug; 37(8):701-5. PubMed ID: 10494604
[TBL] [Abstract][Full Text] [Related]
15. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
Cavallini G; Tittobello A; Frulloni L; Masci E; Mariana A; Di Francesco V
N Engl J Med; 1996 Sep; 335(13):919-23. PubMed ID: 8786777
[TBL] [Abstract][Full Text] [Related]
16. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
[TBL] [Abstract][Full Text] [Related]
17. A comparison of serum trypsinogen-2 and trypsin-2-alpha1-antitrypsin complex with lipase and amylase in the diagnosis and assessment of severity in the early phase of acute pancreatitis.
Hedström J; Kemppainen E; Andersén J; Jokela H; Puolakkainen P; Stenman UH
Am J Gastroenterol; 2001 Feb; 96(2):424-30. PubMed ID: 11232685
[TBL] [Abstract][Full Text] [Related]
18. Can somatostatin prevent injection pancreatitis after ERCP?
Persson B; Slezak P; Efendic S; Häggmark A
Hepatogastroenterology; 1992 Jun; 39(3):259-61. PubMed ID: 1380475
[TBL] [Abstract][Full Text] [Related]
19. [Octreotide in the prevention of hyperamylasemia following ERCP (a controlled multicenter study)].
Döbrönte Z; Juhász L; Tulassay Z
Orv Hetil; 1996 Oct; 137(42):2309-12. PubMed ID: 8992429
[TBL] [Abstract][Full Text] [Related]
20. Correlation between serum concentrations of three specific exocrine pancreatic proteins and pancreatic duct morphology at ERCP examinations.
Borgström A; Wehlin L
Scand J Gastroenterol; 1984 Mar; 19(2):220-7. PubMed ID: 6201996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
